Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP250797.RAkwz9KimsCPzGiD-RL6E4bd6520Q1_rb0sNeKGKzrUvU130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP250797.RAkwz9KimsCPzGiD-RL6E4bd6520Q1_rb0sNeKGKzrUvU130_provenance.
• NP646598.RARt3LKTzKUvYQeHl123vqLpI2yQJPl_u2NhSj-iFSuoQ130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646598.RARt3LKTzKUvYQeHl123vqLpI2yQJPl_u2NhSj-iFSuoQ130_provenance.
• NP870000.RAd0ErbX7UQhNHSLM2oK6BgzHqqsXmoWqCdx2wa1AbDYU130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870000.RAd0ErbX7UQhNHSLM2oK6BgzHqqsXmoWqCdx2wa1AbDYU130_provenance.
• NP627527.RA7Hd3JeDkDm_tQnfO8CiiK8bTJOsuiUP_cGPi4fpRGYw130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627527.RA7Hd3JeDkDm_tQnfO8CiiK8bTJOsuiUP_cGPi4fpRGYw130_provenance.
• assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP419565.RAalK84FOdI-Jufhf-AiVI7wv0vcYexxTnN4a_xz1zfls130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419565.RAalK84FOdI-Jufhf-AiVI7wv0vcYexxTnN4a_xz1zfls130_provenance.
• assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP419412.RAhTcDDf4H83OxyKdmVftqiyx_7Wtof7oARBPckmzzP2A130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419412.RAhTcDDf4H83OxyKdmVftqiyx_7Wtof7oARBPckmzzP2A130_provenance.
• NP558518.RAkdxTXOYRbfGJKvGfiwnZKzU2O9nVvWUhmljdx2fblS0130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558518.RAkdxTXOYRbfGJKvGfiwnZKzU2O9nVvWUhmljdx2fblS0130_provenance.
• NP972983.RAJF4vtJnmEj2Jsas8JRIx_kjBzRQ8JgKYuCDwQ9WsWAA130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP972983.RAJF4vtJnmEj2Jsas8JRIx_kjBzRQ8JgKYuCDwQ9WsWAA130_provenance.
• NP558528.RALXwsf1Me4SNOQEcvrBdUGU9aO4WSx8WKBbDwK0a9Y9Q130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558528.RALXwsf1Me4SNOQEcvrBdUGU9aO4WSx8WKBbDwK0a9Y9Q130_provenance.
• NP558532.RAJ89mRu_vrcIW3NhmoVGHa8ZH6Eh7CHNKDCxKTLtLohs130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558532.RAJ89mRu_vrcIW3NhmoVGHa8ZH6Eh7CHNKDCxKTLtLohs130_provenance.
• NP973007.RA1INuoukQCc53JLdi8tGSTMdfuNU3D3Cu0zQqVSE3oEs130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973007.RA1INuoukQCc53JLdi8tGSTMdfuNU3D3Cu0zQqVSE3oEs130_provenance.
• NP558527.RAx86XZd2fWtNoVV2vf3mZxjA_VVTYtEoBBmU3xQHFWKc130_assertion description "[GATA-4/-5 promoter methylation was not detected in normal esophageal mucosa, but GATA-4 methylation was present in 27 of 44 (61%) squamous carcinomas and 31 of 44 (71%) adenocarcinoma of the esophagus, while GATA-5 methylation was present in 14 of 44 (32%) squamous carcinomas and 24 of 44 (55%) adenocarcinoma of the esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558527.RAx86XZd2fWtNoVV2vf3mZxjA_VVTYtEoBBmU3xQHFWKc130_provenance.